Agomelatine

WITHDRAWN · NA · Depressive Disorder, Major

This study not get the approval by the drug company

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.